Gilead Sciences announced this Friday that it will launch ALL4LIVER Scholarship Program 2023, With “Diagnostics” as the motto. derived. “Priority” aims to support innovative projects that advance diagnostics, improve connections to healthcare and help Put treatments for viral hepatitis high on the public health agenda. ALL4LIVER will support initiatives targeting hepatitis C, B or D around the world (except in the US).
organization can Submit a funding request online Through the Gilead Grants Portal Before September 30, 2023. Applications will be reviewed by an independent international committee of experts (excluding the United States) in the field of viral hepatitis. Review board members are recognized for their expertise in viral hepatitis research, public health or patient advocacy.
In 2016, the World Health Organization (WHO) established The goal of eliminating viral hepatitisBy 2030, it will become a public health threat. With only seven years left to achieve this goal, A global approach is urgently needed in all areas Associated with viral hepatitis. Gilead said it has been working to improve the lives of people living with viral hepatitis for more than two decades and remains committed to helping eliminate viral hepatitis through community-based organizations. To this end, it supports innovative programs that address the unmet needs of people living with viral hepatitis around the world, he added.
“The disruption caused by the covid-19 pandemic is far-reaching”Danjuma Kamrun Ada, President of the World Hepatitis Alliance. “Now more than ever, support from initiatives like Gilead’s ALL4LIVER grant is critical to ensuring that viral hepatitis continues to receive the attention it deserves, and that we continue to develop innovative strategies to eliminate viral hepatitis. “
“The expansion of Gilead’s fellowship program ALL4LIVER 2023 reflects We are committed to addressing the pressing global challenge of viral hepatitis Creating a healthier future for all people with liver disease. By empowering community organizations, we aim to promote liver health and help make viral hepatitis elimination a reality by 2030. said Alex Kalomparis, senior vice president of public affairs at Gilead Sciences.
this ALL4LIVER scholarship launched in 2021 Originally for APAC Has received more than $1 million in grants Support initiatives to improve viral hepatitis education, with a focus on chronic hepatitis B in the region. Gilead expands ALL4LIVER globally, supporting programs in Europe, Africa, South America, Asia, Colombia and North America (excluding the United States).